Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Hoyoung Huh
AddedMar 31, 2024
UpdatedJun 28, 2026
Hoyoung Huh

Hoyoung Huh

Founder & CEO, pH Pharma

CrunchbaseLinkedIn

Hoyoung Huh's Career

pH Pharma
pH Pharma

Seoul, Seoul, KR

Founder & CEO· C-Suite · Management
Peak Bio
Peak Bio

Palo Alto, CA, US

Founder
Pliant Therapeutics
Pliant Therapeutics

South San Francisco, CA, US

Board Member· Board
CytomX Therapeutics
CytomX Therapeutics

South San Francisco, CA, US

Board Member· Board
Geron
Geron

Menlo Park, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Hoyoung Huh's Career

pH Pharma
pH Pharma
Angel1752015Seoul, Seoul, KR
Founder & CEO· C-Suite · Management
Peak Bio
Peak Bio
Public$25M302015Palo Alto, CA, US
Founder
Pliant Therapeutics
Pliant Therapeutics
Public$694.9M1242015South San Francisco, CA, US
Board Member· Board

Leadership at Pliant Therapeutics

David PyottDavid PyottBoard Member
Smital ShahSmital ShahBoard Member
Charles HomcyCharles HomcyBoard Member
Perry KarsenPerry KarsenBoard Member
Katharine KnobilKatharine KnobilBoard Member
Suzanne BruhnSuzanne BruhnBoard Member
CytomX Therapeutics
CytomX Therapeutics
Public$345.4M1742010South San Francisco, CA, US
Board Member· Board

Leadership at CytomX Therapeutics

Fred GluckFred GluckCo-Founder
Patrick DaughertyPatrick DaughertyCo-Founder
Halley GilbertHalley GilbertBoard Member
Sean A. McCarthySean A. McCarthyBoard Member
Matt YoungMatt YoungBoard Member
Elaine V. JonesElaine V. JonesBoard Member
Geron
Geron
Public$599.5M1071990Menlo Park, CA, US
Board Member· Board

Recent news

Germ brings end-to-end encrypted messages to BlueskyStartups | TechCrunch · 2025
Germ brings end-to-end encrypted messages to BlueskyTechCrunch · 2025

Leadership at Geron

John A. ScarlettJohn A. ScarlettCEO
Robert SpiegelRobert SpiegelBoard Member
Bryan LawlisBryan LawlisBoard Member
Michael D. WestMichael D. WestFounder
Dawn BirDawn BirBoard Member
Karin EasthamKarin EasthamBoard Member

Similar to Geron

GenentechGenentechSouth San Francisco, CA, USBiopharmaceuticalsest. 1976GenentechSouth San Francisco, CA, US · est. 1976

Genentech, Inc.: A pioneering US biotech firm, operating as an independent subsidiary of Roche.

Public13.5k
Kyntra BioKyntra BioSan Francisco, CA, USPharmaceuticalsest. 1993Kyntra BioSan Francisco, CA, US · est. 1993

FibroGen, Inc: A global, research-based pharmaceutical company in San Francisco, innovating treatments for unmet medical needs.

Public · $188M592
MacroGenicsMacroGenicsRockville, MD, USest. 2000MacroGenicsRockville, MD, US · est. 2000

US-based MacroGenics, Inc. develops novel biologics for cancer, autoimmune disorders, and infectious diseases.

Public · $165.9M357
Gerostate AlphaGerostate AlphaNovato, CA, USPharmaceuticalsest. 2018Gerostate AlphaNovato, CA, US · est. 2018

Gerostate Alpha: A pharmaceutical company innovating in aging and age-related disease treatment.

Seed · $150k

Hoyoung Huh's Co-Investors

Yoky MatsuokaYoky MatsuokaCo-invested · Good2Go SeedBob PaveyBob PaveyCo-invested · Good2Go SeedCorey GoodmanCorey GoodmanCo-invested · Good2Go SeedCarol GallagherCarol GallagherCo-invested · Good2Go SeedJohn ElstrottJohn ElstrottCo-invested · Good2Go SeedUjjwal SinghUjjwal SinghCo-invested · Good2Go SeedShailesh RaoShailesh RaoCo-invested · Good2Go SeedJoe SchoendorfJoe SchoendorfCo-invested · Good2Go Seed

Hoyoung Huh's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Hoyoung Huh

Ronald GoldRonald GoldBoard Member · NJ BioJohn FunkhouserJohn FunkhouserCEO · PharmaneticsAnne Chun LongoAnne Chun LongoCEO · PharmatrophixAlan RudolphAlan RudolphCEO · PhotonpharmaBill CrossmanBill CrossmanCEO · Phoenix PharmaLabsAnil GulatiAnil GulatiFounder · Endogenx